New York
How Bruesewitz v. Wyeth LLC applies in New York: state-specific rules, key cases, and bar exam notes for Products Liability (Preemption).
New York courts uphold the principles of federal preemption in products liability cases, recognizing that federal law may supersede state liability claims if they relate to FDA-approved products. However, New York law allows for state law claims to the extent they do not conflict with federal regulations.
Under New York law, a plaintiff must demonstrate that a product was defectively designed or manufactured, and that such defect directly caused injuries, unless federal preemption applies due to compliance with federal regulations.
The court held that state law claims were preempted by federal regulations governing pharmaceuticals.
The court ruled that because federal approval was obtained for the dental product in question, plaintiffs' claims were subject to federal preemption.
The court determined that the federal regulatory framework for dietary supplements preempted certain state tort claims.
Federal courts typically apply a broad interpretation of preemption under the National Childhood Vaccine Injury Act, as seen in Bruesewitz. Conversely, New York's application allows for the possibility of state claims if they do not conflict directly with federal statutes, emphasizing the importance of state law principles.
Understanding the interplay between state and federal preemption in products liability is crucial for the New York bar exam, especially in questions involving pharmaceutical and vaccine-related claims.